Browse by author
Lookup NU author(s): Dr Jana SuklanORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2024 Elsevier LtdThe COVID-19 pandemic triggered disruptions to health care and lifestyles that could conceivably impact diabetes management. We set out to identify the impact of disruptions caused by COVID-19 on clinical outcomes in people with diabetes. We performed a systematic review of the available literature in the MEDLINE and OVID databases from Jan 1, 2020, to June 7, 2023, and included 138 studies (n>1 000 000 people). All but five studies were judged to be at some risk of bias. All studies compared prepandemic with pandemic periods. All-cause mortality (six studies) and diabetes-related mortality (13 studies) showed consistent increases, and most studies indicated increases in sight loss (six studies). In adult and mixed samples, data generally suggested no difference in diabetic ketoacidosis frequency or severity, whereas in children and adolescents most studies showed increases with some due to new-onset diabetes (69 studies). Data suggested decreases in hospital admissions in adults but increases in diabetes-related admissions to paediatric intensive care units (35 studies). Data were equivocal on diabetic foot ulcer presentations (nine studies), emergency department admissions (nine studies), and overall amputation rates (20 studies). No studies investigated renal failure. Where reported, the impact was most pronounced for females, younger people, and racial and ethnic minority groups. Further studies are needed to investigate the longer-term impact of the pandemic and the on potential differential impacts, which risk further exacerbating existing inequalities within people with diabetes.
Author(s): Hartmann-Boyce J, Highton P, Rees K, Onakpoya I, Suklan J, Curtis F, O'Mahoney L, Morris E, Kudlek L, Morgan J, Lynch R, Marpadga S, Seidu S, Khunti K
Publication type: Review
Publication status: Published
Journal: The Lancet Diabetes and Endocrinology
Year: 2024
Volume: 12
Issue: 2
Pages: 132-148
Online publication date: 23/01/2024
Acceptance date: 02/04/2018
ISSN (print): 2213-8587
ISSN (electronic): 2213-8595
Publisher: Elsevier Ltd
URL: https://doi.org/10.1016/S2213-8587(23)00351-0
DOI: 10.1016/S2213-8587(23)00351-0
PubMed id: 38272607